Metabolic effects of reduced growth hormone action in fatty liver disease

Authors: Fernández-Ramos D, Fernández-Tussy P, Lopitz-Otsoa F, Gutiérrez-de-Juan V, Navasa N, Barbier-Torres L, Zubiete-Franco I, Simón J, Fernández AF, Arbelaiz A, Aransay AM, Lavín JL, Beraza N, Perugorria MJ, Banales JM, Villa E, Fraga MF, Anguita J, Avila MA, Berasain C, Iruzibieta P, Crespo J, Lu SC, Varela-Rey M, Mato JM, Delgado TC, Martínez-Chantar ML. Rufinatscha K, Ress C, Folie S, Haas S, Salzmann K, Moser P, Dobner J, Weiss G, Iruzubieta P, Arias-Loste MT, Crespo J, Tilg H, Kaser S.
Hepatol Int. 2018 Sep;12(5):474-481. doi: 10.1007/s12072-018-9893-7. Epub 2018 Sep 11. PubMed: 30206761
Mostrar Más
PMID: 30206761
Title: Metabolic effects of reduced growth hormone action in fatty liver disease
Authors: Fernández-Ramos D, Fernández-Tussy P, Lopitz-Otsoa F, Gutiérrez-de-Juan V, Navasa N, Barbier-Torres L, Zubiete-Franco I, Simón J, Fernández AF, Arbelaiz A, Aransay AM, Lavín JL, Beraza N, Perugorria MJ, Banales JM, Villa E, Fraga MF, Anguita J, Avila MA, Berasain C, Iruzibieta P, Crespo J, Lu SC, Varela-Rey M, Mato JM, Delgado TC, Martínez-Chantar ML. Rufinatscha K, Ress C, Folie S, Haas S, Salzmann K, Moser P, Dobner J, Weiss G, Iruzubieta P, Arias-Loste MT, Crespo J, Tilg H, Kaser S.
Citation: Hepatol Int. 2018 Sep;12(5):474-481. doi: 10.1007/s12072-018-9893-7. Epub 2018 Sep 11.
First Author: Rufinatscha K
Journal/Book: Hepatol Int
Publication Year: 2018
Create Date: 2018/09/13
PMCID: PMC6208861
NIHMS ID:
DOI: 10.1007/s12072-018-9893-7